H16 News
×
Logo

Stories

Topics
Polls
Our Team
Settings
Feedback
Login

By Swaleha | Published on May 29, 2025

Image Not Found
Health / May 29, 2025

Why the JN.1 Covid-19 variant is spreading like wildfire in India

India is better prepared than before, with widespread vaccine availability and improved testing and treatment protocols. JN.1 is a reminder, not a threat—caution and common sense remain our best defenses.

New Delhi: 

As India continues to adapt to the post-pandemic world, a new COVID-19 variant, JN.1, is making headlines due to its rapid spread. Though current vaccines and past infections continue to offer protection, JN.1’s unique mutations make it more transmissible, raising public health concerns. Dr Suchismitha Rajamanya, Lead Consultant & HOD – Internal Medicine, Aster Whitefield Hospital, Bengaluru, explained why JN.1 variant of COVID-19 is spreading at a rapid pace in India.

What Is JN.1 and Why Is It Spreading?

JN.1 is a sub-lineage of the BA.2.86 (Pirola) variant, itself a descendant of the Omicron family. Detected globally in late 2023 and recently in several Indian states, JN.1 carries mutations in the spike protein that allow it to attach more effectively to human cells. This leads to:

Partial immune escape – can infect those previously vaccinated or infected

Potentially shorter incubation – symptoms may appear sooner after exposure

Increased transmissibility – spreads faster from person to person

But these are just a few observations that ongoing studies have come up with. It does not indicate that JN.1 is more dangerous than the previous Omicron variants we have seen in the past. Fever, tiredness, a sore throat, and temporary digestive discomfort are the usual symptoms that were noticed earlier and are being noticed now as well. Still, it is advised to practice caution, especially when it comes to the elderly or people who already suffer from chronic diseases, as they have weaker immune systems.

Are Vaccines Still Effective?

Yes. Vaccines, especially when boosted, continue to protect against severe disease, hospitalization, and death. While JN.1 may partially evade antibody responses, the body’s T-cell immunity remains strong and effective. Updated booster shots designed to target newer variants—like those from the XBB lineage—offer better protection against JN.1. These are available in India, but uptake remains limited.

Should We Be Concerned?

There’s no need for panic, but awareness and preventive measures are important. JN.1 shows that COVID-19 is still evolving and may appear in periodic waves, especially during seasonal changes and festive gatherings.

Wear a mask in crowded or enclosed spaces

Maintain hygiene and avoid exposure if feeling unwell

Take extra precautions for elderly and immunocompromised individuals

Not worried – but aware and prepared

Stay up to date with vaccinations and booster doses

India is better prepared than before, with widespread vaccine availability and improved testing and treatment protocols. JN.1 is a reminder, not a threat—caution and common sense remain our best defenses.

In summary, JN.1 is highly contagious but not more severe than earlier variants. Vaccines still work, especially in preventing serious illness. Staying updated, practicing basic precautions, and being mindful of vulnerable groups can help us navigate this phase safely. COVID-19 may be evolving, but so are we.

Read More:

IndiGo set to become founding carrier at Navi Mumbai International Airport

 

 

logo

HSRNEWS

Instant News. Infinite Insights

© gokakica.in. All Rights Reserved. Designed by Image Computer Academy